Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 12, Special Issue 8 (2023)

A comparative study of constraints in the cultivation and marketing of gram in Narsinghpur district of Madhya Pradesh state in India

Author(s):
Ankit Soni, Dr. DP Rai, Pradeep Patidar, Shiva Yadav and Dronak K Sahu
Abstract:
The study was limited to Narsinghpur district of Madhya Pradesh. Narsinghpur district consists of six blocks. Narsinghpur, Gotegaon, Chawarpatha, Chichli, Saikheda and Kareli districts of Madhya Pradesh were selected purposefully as gram is the main rabi crop in pulses in the district. Chickpea is a viable crop because of its consistent yield and low price volatility, and its adoption by farmers even with low yield potential indicates that it is economically viable. Chickpea (Cicer arietinum L.) is the most important pulse crop of India with an area of more than six million hectares. It is mainly grown under soil moisture conditions which decrease during the rainy season as a rainfed crop. On an average, marketable surplus was 92.54% and marketable surplus was observed at 89.91%. On an average, chana growers disposed 72.94% of chana through tractor cars followed by bullock-drawn carts (27.06%). The maximum number of grams available through channel II was produced by small, medium and large farmers, i.e. 63.09%, 70.90% and 79.78% using channel III. The details of marketing cost under Channel 1, Channel II and Channel III are Rs. 38/quint, Rs. 45/quint and Rs. 50/quint was told. Channel III had the highest total marketing cost (Rs.193/qtl), followed by Channel II at Rs.105/qtl and Channel I at Rs.38/qtl.
Pages: 2061-2064  |  109 Views  51 Downloads
How to cite this article:
Ankit Soni, Dr. DP Rai, Pradeep Patidar, Shiva Yadav and Dronak K Sahu. A comparative study of constraints in the cultivation and marketing of gram in Narsinghpur district of Madhya Pradesh state in India. The Pharma Innovation Journal. 2023; 12(8S): 2061-2064.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal


Call for book chapter